Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totaling 246 shares, a growth of ? from the April 30th total of 0 shares. Based on an average trading volume of 186 shares, the short-interest ratio is presently 1.3 days.
Hikma Pharmaceuticals Price Performance
Shares of OTCMKTS HKMPY remained flat at $39.18 during mid-day trading on Monday. The company had a trading volume of 100 shares, compared to its average volume of 1,559. The stock has a 50 day moving average of $36.88 and a two-hundred day moving average of $39.42. Hikma Pharmaceuticals has a one year low of $31.80 and a one year high of $56.91.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
- Was Hormel’s Q2 Earnings Report the Turnaround Investors Needed?
- 3 Active ETFs to Ride the Hands-On Management Trend
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
